791 related articles for article (PubMed ID: 29789015)
1. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.
Panebianco C; Andriulli A; Pazienza V
Microbiome; 2018 May; 6(1):92. PubMed ID: 29789015
[TBL] [Abstract][Full Text] [Related]
2. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
[TBL] [Abstract][Full Text] [Related]
3. Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
Conti G; D'Amico F; Fabbrini M; Brigidi P; Barone M; Turroni S
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672796
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
[TBL] [Abstract][Full Text] [Related]
5. Synbiotics, prebiotics and probiotics for solid organ transplant recipients.
Cooper TE; Scholes-Robertson N; Craig JC; Hawley CM; Howell M; Johnson DW; Teixeira-Pinto A; Jaure A; Wong G
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014804. PubMed ID: 36126902
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome modulation by probiotics, prebiotics, synbiotics and postbiotics: a novel strategy in food allergy prevention and treatment.
Shi J; Wang Y; Cheng L; Wang J; Raghavan V
Crit Rev Food Sci Nutr; 2024; 64(17):5984-6000. PubMed ID: 36576159
[TBL] [Abstract][Full Text] [Related]
7. Auxiliary antitumor effects of fungal proteins from Hericium erinaceus by target on the gut microbiota.
Wang D; Zhu X; Tang X; Li H; Yizhen X; Chen D
J Food Sci; 2020 Jun; 85(6):1872-1890. PubMed ID: 32460371
[TBL] [Abstract][Full Text] [Related]
8. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
Ciernikova S; Sevcikova A; Drgona L; Mego M
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
[TBL] [Abstract][Full Text] [Related]
9. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome-targeted therapies for Alzheimer's disease.
Zhang T; Gao G; Kwok LY; Sun Z
Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota modulation of chemotherapy efficacy and toxicity.
Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
13. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
[TBL] [Abstract][Full Text] [Related]
14. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
Cho MS; Kim SY; Suk KT; Kim BY
J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism.
Lambert K; Rinninella E; Biruete A; Sumida K; Stanford J; Raoul P; Mele MC; Wang AY; Mafra D
J Ren Nutr; 2023 Nov; 33(6S):S30-S39. PubMed ID: 37632511
[TBL] [Abstract][Full Text] [Related]
16. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
Wei Y; Peng S; Lian C; Kang Q; Chen J
Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
[TBL] [Abstract][Full Text] [Related]
17. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy.
Chattopadhyay I; Nandi D; Nag A
Semin Cancer Biol; 2021 May; 70():98-111. PubMed ID: 32739479
[TBL] [Abstract][Full Text] [Related]
18. Overview of the Importance of Biotics in Gut Barrier Integrity.
Kocot AM; Jarocka-Cyrta E; Drabińska N
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
[TBL] [Abstract][Full Text] [Related]
19. Microbiome Disturbances and Autism Spectrum Disorders.
Rosenfeld CS
Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
[TBL] [Abstract][Full Text] [Related]
20. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
